60 Degrees Pharmaceuticals closes $2.4M public offering of units and pre-funded units

60 DEGREES PHARMACEUTICALS, INC.

Gross proceeds ~$2.4M; net proceeds ~$1.9M after underwriter discounts and expenses.
Offering included 5,260,901 units at $0.385/unit and 999,076 pre-funded units at $0.375/unit.
Each unit consists of one share of common stock and one warrant (exercise price $0.4235, 5-year term).
Underwriters partially exercised over-allotment for 818,177 warrants.
Net proceeds to fund working capital, relaunch of ARAKODA malaria prevention, and R&D.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.